Video

Examining new biological treatments in posterior uveitis

Author(s):

Sheryl Stevenson,OT Staff Reports

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, highlights his presentation regarding new biological treatments of posterior uveitis.

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University School of Medicine, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.

See more EURETINA coverage

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
NICE approves idebenone for LHON in the UK
August 9th 2025

NICE approves idebenone for LHON in the UK

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 9th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program
August 9th 2025

Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program

EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
August 9th 2025

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

Q&A: PER-001 showed improved structure and visual function in patients with diabetic retinopathy
August 9th 2025

Q&A: PER-001 showed improved structure and visual function in patients with diabetic retinopathy

From blindness to breakthrough: Milestones that changed ophthalmology forever
August 9th 2025

From blindness to breakthrough: Milestones that changed ophthalmology forever

© 2025 MJH Life Sciences

All rights reserved.